Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Horizon Diagnostics' Quantitative Multiplex DNA Reference Standard

Premium

Horizon Diagnostics has launched the Quantitative Multiplex DNA Reference Standard, a standard intended for researchers assessing multiple biomarkers in a single next-generation sequencing assay.

Horizon said the standard enables researchers to quantify a range of detection thresholds for 11 cancer-relevant mutations. It is currently available as genomic DNA and the company is also working on a matched formalin-fixed paraffin-embedded format to be launched later this year.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.